Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient?

IF 4.7 Q1 VIROLOGY Tumour Virus Research Pub Date : 2021-06-01 DOI:10.1016/j.tvr.2021.200216
Megan A. Smith , Karen Winch , Karen Canfell , Julia ML. Brotherton
{"title":"Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient?","authors":"Megan A. Smith ,&nbsp;Karen Winch ,&nbsp;Karen Canfell ,&nbsp;Julia ML. Brotherton","doi":"10.1016/j.tvr.2021.200216","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Initially, three-dose schedules were recommended for vaccines against human papillomavirus (HPV); subsequently recommendations have been updated to a schedule of two doses delivered at least six (minimum five) months apart for those aged &lt;15 years at dose 1. We aimed to re-estimate effective HPV vaccination coverage in Australia, considering reduced-dose schedules and possible one-dose effectiveness. We also aimed to identify which of the three school visits was most commonly missed amongst two-dose only recipients, to inform optimal timing of visits.</p></div><div><h3>Methods</h3><p>National vaccination register data were used to estimate: i) vaccination coverage at December 2017, either with a complete course (three or two sufficiently-spaced doses (&gt;151 days apart)), or at least one dose; ii) for each birth cohort offered vaccination, the percentage of the initially targeted cohort with a complete course, or at least one dose (reflecting uptake at the time the vaccine was offered); and iii) among two-dose only recipients, the percentage who missed each of three school visits.</p></div><div><h3>Results</h3><p>Including those with two sufficiently-spaced doses increased end-2017 coverage by 1.3–2.8% points in those vaccinated at school. Including those with at least one dose increased coverage further, by 6.5–9.5% points, mostly due to including those receiving multiple too-closely-spaced doses. One-dose coverage reached 90.9% and 86.9% in females and males respectively born in 2002.</p><p>Among those vaccinated at school who received only two doses, it was much more common to miss the first (31.0% females; 32.5% males) or the third visit in the school year (54.6% females; 48.6% males) than the second (14.1% females; 18.8% males).</p></div><div><h3>Conclusions</h3><p>Including those with two sufficiently-spaced doses has a very modest impact on HPV vaccine coverage in Australia. If receiving at least one dose offers substantial protection, these data suggest that the school-based program is now achieving close to 90% coverage on this measure.</p></div>","PeriodicalId":52381,"journal":{"name":"Tumour Virus Research","volume":null,"pages":null},"PeriodicalIF":4.7000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.tvr.2021.200216","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumour Virus Research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666679021000069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 7

Abstract

Background

Initially, three-dose schedules were recommended for vaccines against human papillomavirus (HPV); subsequently recommendations have been updated to a schedule of two doses delivered at least six (minimum five) months apart for those aged <15 years at dose 1. We aimed to re-estimate effective HPV vaccination coverage in Australia, considering reduced-dose schedules and possible one-dose effectiveness. We also aimed to identify which of the three school visits was most commonly missed amongst two-dose only recipients, to inform optimal timing of visits.

Methods

National vaccination register data were used to estimate: i) vaccination coverage at December 2017, either with a complete course (three or two sufficiently-spaced doses (>151 days apart)), or at least one dose; ii) for each birth cohort offered vaccination, the percentage of the initially targeted cohort with a complete course, or at least one dose (reflecting uptake at the time the vaccine was offered); and iii) among two-dose only recipients, the percentage who missed each of three school visits.

Results

Including those with two sufficiently-spaced doses increased end-2017 coverage by 1.3–2.8% points in those vaccinated at school. Including those with at least one dose increased coverage further, by 6.5–9.5% points, mostly due to including those receiving multiple too-closely-spaced doses. One-dose coverage reached 90.9% and 86.9% in females and males respectively born in 2002.

Among those vaccinated at school who received only two doses, it was much more common to miss the first (31.0% females; 32.5% males) or the third visit in the school year (54.6% females; 48.6% males) than the second (14.1% females; 18.8% males).

Conclusions

Including those with two sufficiently-spaced doses has a very modest impact on HPV vaccine coverage in Australia. If receiving at least one dose offers substantial protection, these data suggest that the school-based program is now achieving close to 90% coverage on this measure.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
澳大利亚有效的HPV疫苗接种覆盖率按剂量数和两剂间隔:如果一剂或两剂就足够了呢?
最初,人类乳头瘤病毒(HPV)疫苗推荐采用三剂接种方案;随后,建议更新为15岁人群两次剂量至少间隔6个月(至少5个月),每次剂量为1。我们的目的是重新估计澳大利亚有效的HPV疫苗接种覆盖率,考虑减少剂量计划和可能的单剂量有效性。我们还旨在确定三种学校访问中哪一种在仅两次剂量的接受者中最常错过,以告知最佳访问时间。方法使用国家疫苗接种登记数据来估计:i) 2017年12月的疫苗接种覆盖率,要么是完整疗程(3次或2次足够间隔的剂量(间隔151天)),要么是至少一次剂量;Ii)对于每个提供疫苗接种的出生队列,最初目标队列中完成整个接种过程或至少一次接种的百分比(反映在提供疫苗时的接种情况);第三,在只注射两次疫苗的接受者中,错过三次学校访问的百分比。结果:包括两次足够间隔剂量的人在内,2017年底在学校接种疫苗的覆盖率提高了1.3-2.8%。包括那些至少接受一次剂量的人,覆盖率进一步提高了6.5-9.5%,这主要是由于包括那些接受多次间隔太近的剂量的人。2002年出生的女性和男性的单剂覆盖率分别达到90.9%和86.9%。在那些在学校只接种了两剂疫苗的人中,错过第一剂疫苗的情况更为常见(31.0%的女性;32.5%男性)或在学年内第三次到访(54.6%女性;男性48.6%),女性14.1%;18.8%的男性)。结论:在澳大利亚,包括两次足够间隔的剂量对HPV疫苗覆盖率的影响非常有限。如果至少接种一剂疫苗就能提供实质性的保护,这些数据表明,以学校为基础的项目目前在这一措施上的覆盖率接近90%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Tumour Virus Research
Tumour Virus Research Medicine-Infectious Diseases
CiteScore
6.50
自引率
2.30%
发文量
16
审稿时长
56 days
期刊最新文献
The imprint of viral oncoproteins on the variable clinical behavior among human papilloma virus-related oropharyngeal squamous cell carcinomas. Genomic diversity of HPV6 and HPV11 in recurrent respiratory papillomatosis: Association with malignant transformation in the lungs and clinical outcomes The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential tumorigenic activity Opportunities to advance cervical cancer prevention and care A new role for human papillomavirus 16 E2: Mitotic activation of the DNA damage response to promote viral genome segregation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1